Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E J Sybertz

Showing results (51-60 of 72) with videos related to

Pageof 8
Sort By:
Naunyn-Schmiedeberg'S Archives of Pharmacology|April 1, 1997
Inhibition of platelet adhesion and aggregation by E4021, a type V phosphodiesterase inhibitor, in guinea pigsP J Chiu, S Vemulapalli, M Chintala, et al.
Hypertension (Dallas, Tex. : 1979)|May 1, 1991
Hemodynamic and hormonal effects of neutral endopeptidase inhibitor SCH 39370 in sheepC J Charles, E A Espiner, V A Cameron, et al.
Journal of Medicinal Chemistry|November 1, 1982
Synthesis and comparison of some cardiovascular properties of the stereoisomers of labetalolE H Gold, W Chang, M Cohen, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1981
Alpha and beta adrenoceptor blocking properties of labetalol and its R,R-isomer, SCH 19927E J Sybertz, C S Sabin, K K Pula, et al.
British Journal of Pharmacology|April 26, 2000
Comparison of the activity and disposition of the novel cholesterol absorption inhibitor, SCH58235, and its glucuronide, SCH60663M van Heek, C Farley, D S Compton, et al.
Journal of Medicinal Chemistry|July 1, 1989
Angiotensin converting enzyme inhibitors: spirapril and related compoundsE M Smith, G F Swiss, B R Neustadt, et al.
American Journal of Hypertension|May 1, 1993
Atrial natriuretic factor potentiating and hemodynamic effects of SCH 42495, a new, neutral metalloendopeptidase inhibitorR W Watkins, S Vemulapalli, P J Chiu, et al.
Journal of Cardiovascular Pharmacology|September 1, 1986
Hemodynamic actions of a synthetic atrial natriuretic factorT Baum, E J Sybertz, R W Watkins, et al.
European Journal of Pharmacology|July 22, 1998
Disparate effects of thrombin receptor activating peptide on platelets and peripheral vasculature in ratsM S Chintala, P J Chiu, V Bernadino, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1989
SCH 39370, a neutral metalloendopeptidase inhibitor, potentiates biological responses to atrial natriuretic factor and lowers blood pressure in desoxycorticosterone acetate-sodium hypertensive ratsE J Sybertz, P J Chiu, S Vemulapalli, et al.
Pageof 8

Showing results (51-60 of 72) with videos related to

Sort By:
Pageof 8
Naunyn-Schmiedeberg'S Archives of Pharmacology|April 1, 1997
Inhibition of platelet adhesion and aggregation by E4021, a type V phosphodiesterase inhibitor, in guinea pigsP J Chiu, S Vemulapalli, M Chintala, et al.
Hypertension (Dallas, Tex. : 1979)|May 1, 1991
Hemodynamic and hormonal effects of neutral endopeptidase inhibitor SCH 39370 in sheepC J Charles, E A Espiner, V A Cameron, et al.
Journal of Medicinal Chemistry|November 1, 1982
Synthesis and comparison of some cardiovascular properties of the stereoisomers of labetalolE H Gold, W Chang, M Cohen, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1981
Alpha and beta adrenoceptor blocking properties of labetalol and its R,R-isomer, SCH 19927E J Sybertz, C S Sabin, K K Pula, et al.
British Journal of Pharmacology|April 26, 2000
Comparison of the activity and disposition of the novel cholesterol absorption inhibitor, SCH58235, and its glucuronide, SCH60663M van Heek, C Farley, D S Compton, et al.
Journal of Medicinal Chemistry|July 1, 1989
Angiotensin converting enzyme inhibitors: spirapril and related compoundsE M Smith, G F Swiss, B R Neustadt, et al.
American Journal of Hypertension|May 1, 1993
Atrial natriuretic factor potentiating and hemodynamic effects of SCH 42495, a new, neutral metalloendopeptidase inhibitorR W Watkins, S Vemulapalli, P J Chiu, et al.
Journal of Cardiovascular Pharmacology|September 1, 1986
Hemodynamic actions of a synthetic atrial natriuretic factorT Baum, E J Sybertz, R W Watkins, et al.
European Journal of Pharmacology|July 22, 1998
Disparate effects of thrombin receptor activating peptide on platelets and peripheral vasculature in ratsM S Chintala, P J Chiu, V Bernadino, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1989
SCH 39370, a neutral metalloendopeptidase inhibitor, potentiates biological responses to atrial natriuretic factor and lowers blood pressure in desoxycorticosterone acetate-sodium hypertensive ratsE J Sybertz, P J Chiu, S Vemulapalli, et al.
Pageof 8